At the time of writing, Healthequity Inc [HQY] stock is trading at $83.53, up 0.69%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HQY shares have gain 1.69% over the last week, with a monthly amount glided 2.76%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 19, March 2024, HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results. In a post published today on Yahoo Finance, Highlights of the fiscal year include:.
From an analyst’s perspective:
Healthequity Inc [NASDAQ: HQY] stock has seen the most recent analyst activity on January 03, 2024, when Barclays initiated its Overweight rating and assigned the stock a price target of $84. Previously, Robert W. Baird upgraded its rating to Outperform on September 21, 2023, and elevated its price target to $87. On October 21, 2022, upgrade upgraded it’s rating to Neutral and revised its price target to $77 on the stock. KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and suggested a price target of $85 on September 16, 2022. Goldman initiated its recommendation with a Sell and recommended $59 as its price target on July 12, 2022. Wells Fargo started tracking with a Overweight rating for this stock on April 11, 2022, and assigned it a price target of $95. In a note dated April 07, 2022, Guggenheim initiated an Buy rating and provided a target price of $89 on this stock.
For the past year, the stock price of Healthequity Inc fluctuated between $48.86 and $84.13. Currently, Wall Street analysts expect the stock to reach $89 within the next 12 months. Healthequity Inc [NASDAQ: HQY] shares were valued at $83.53 at the most recent close of the market. An investor can expect a potential return of 6.55% based on the average HQY price forecast.
Analyzing the HQY fundamentals
According to Healthequity Inc [NASDAQ:HQY], the company’s sales were 971.04M for trailing twelve months, which represents an 15.33% jump. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.02 and Total Capital is 0.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.47.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 82.63 points at the first support level, and at 81.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 84.06, and for the 2nd resistance point, it is at 84.60.
Healthequity Inc [HQY] reported earnings per share of $0.6 for its fiscal quarter that ended on 10/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.5/share, meaning a difference of $0.1 and a surprise factor of 20.00%. By comparison, the stated earnings for the previous quarter ended on 7/30/2023 were $0.53 per share as compared to estimates of $0.48 per share, a difference of $0.05 representing a surprise of 10.40%.
Ratios To Look Out For
It is important to note that Healthequity Inc [NASDAQ:HQY] has a current ratio of 4.93. As well, the Quick Ratio is 4.93, while the Cash Ratio is 3.47. Considering the valuation of this stock, the price to sales ratio is 7.38, the price to book ratio is 3.61 and price to earnings (TTM) ratio is 248.60.
Transactions by insiders
Recent insider trading involved Ladd Delano, EVP, GC & CORPORATE SECRETARY, that happened on Mar 01 ’24 when 2558.0 shares were sold. EVP, GC & CORPORATE SECRETARY, Ladd Delano completed a deal on Feb 09 ’24 to sell 2499.0 shares. Meanwhile, EVP, GC & CORPORATE SECRETARY Ladd Delano sold 2586.0 shares on Jan 08 ’24.
